Valuation: Danaher Corporation

Market Cap 161B 147B 136B 122B 230B 15,027B 240B 1,638B 647B 8,111B 603B 591B 25,613B P/E 2026 *
36.3x
P/E 2027 * 30.4x
Enterprise Value 181B 165B 153B 138B 260B 16,950B 270B 1,847B 730B 9,149B 681B 666B 28,890B EV / Sales 2026 *
6.91x
EV / Sales 2027 * 6.25x
Free-Float
70.56%
Yield 2026 *
0.63%
Yield 2027 * 0.69%
1 day+0.75%
1 week-1.51%
Current month-1.54%
1 month+1.88%
3 months+8.11%
6 months+36.88%
Current year-0.12%
1 week 225.07
Extreme 225.07
233.76
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%-1.51%+2.81%+8.35% 161B
+0.98%-0.48%+21.31%+48.41% 257B
-0.34%-4.45%-25.56%+35.00% 146B
-0.03%-1.27%-55.01%-19.87% 63.26B
-0.14%-1.13%+21.60%+55.68% 60.51B
+0.42%+0.25%+6.14%-12.18% 53.46B
+1.31%+3.26%+23.72%+56.73% 49.99B
-1.45%-8.78%+1.05%+54.37% 44.88B
+0.09%+0.35%+23.27%+77.75% 45.81B
-0.94%+1.06%+14.38%+12.78% 37.83B
Average +0.09%-2.93%+3.37%+31.70% 92B
Weighted average by Cap. +0.33%-3.74%+3.47%+32.27%

Financials

2026 *2027 *
Net sales 26.26B 23.95B 22.14B 19.98B 37.64B 2,454B 39.12B 267B 106B 1,325B 98.52B 96.46B 4,183B 28.28B 25.79B 23.85B 21.52B 40.53B 2,643B 42.13B 288B 114B 1,427B 106B 104B 4,505B
Net income 4.4B 4.01B 3.71B 3.35B 6.3B 411B 6.55B 44.77B 17.7B 222B 16.49B 16.15B 700B 5.22B 4.76B 4.4B 3.97B 7.47B 487B 7.77B 53.11B 20.99B 263B 19.57B 19.16B 831B
Net Debt 20.58B 18.77B 17.35B 15.66B 29.49B 1,923B 30.66B 210B 82.84B 1,038B 77.2B 75.58B 3,278B 16.09B 14.67B 13.56B 12.24B 23.05B 1,503B 23.96B 164B 64.75B 811B 60.35B 59.08B 2,562B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
19/11/26 US$229.42 +0.37% 263,809
18/11/26 US$228.58 +1.24% 2,942,980
17/11/26 US$225.77 -1.80% 3,561,887
16/11/26 US$229.91 -1.33% 3,233,236
13/11/26 US$233.02 +0.37% 3,359,568
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
228.58USD
Average target price
259.90USD
Spread / Average Target
+13.70%